Sullivan, Mark R. https://orcid.org/0000-0001-5765-0459
McGowen, Kerry
Liu, Qiang
Akusobi, Chidiebere
Young, David C.
Mayfield, Jacob A.
Raman, Sahadevan
Wolf, Ian D.
Moody, D. Branch https://orcid.org/0000-0003-2306-3058
Aldrich, Courtney C.
Muir, Alexander
Rubin, Eric J. https://orcid.org/0000-0001-5120-962X
Funding for this research was provided by:
Damon Runyon Cancer Research Foundation (DRG-2415-20)
U.S. Department of Health & Human Services | NIH | National Institute of Allergy and Infectious Diseases (R01 AI049313, R21AI156772)
U.S. Department of Health & Human Services | NIH | National Heart, Lung, and Blood Institute (U19 AI162584)
Article History
Received: 20 July 2022
Accepted: 14 December 2022
First Online: 19 January 2023
Competing interests
: D.B.M consults with Pfizer and EnaraBio. The other authors declare no competing interests.